{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"thrombocytopenia-5","columns":[{"gene":"","key":"population-795be56ceffdea34665e","label":"Thrombocytopenia 5","mondoId":"MONDO:0014536","onsetQualifier":null,"originColumnKey":"MONDO:0014536/OMIM:616216","originalViews":[{"key":"MONDO:0014536/OMIM:616216","label":"Thrombocytopenia 5","scopeLabel":"OMIM:616216","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0d1742aaff912217a2aff6a768e5321f7b2411feb5c82121443b13c8d4fb212b","238631592896eda6532c9058390161d5660b59dcd7819648ce345ce482f6b5d1","3fde9746ba28d4b0de355813ca9d3fa6d855cfb9d6780bcb0823e0d3122af8a7","870cd129360ae10ae546ed9538fbbe4cccef54146abed86de8a8feaeb3895848","b98e51d39845ac64a11d29076948b30f633189e8d1b25f69b62e36a45f15db7f","c073894847c1ce19791a0f193c71e8675ed6db731e101f997ef9e7adc1ee4715","caa90bde90ae08f10a2563c1bd7211b21dd2f19599dfe14415556ae1e015f192","cb8ddb383fd0221b653e55320f4f1695f85e87277c387559f61cb3ea0aa30d00"],"recordQualifiers":{},"scopeLabel":"OMIM:616216","sourceIds":["OMIM:616216"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-795be56ceffdea34665e"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001903","HP:0004812","HP:0000978","HP:0001875","HP:0000421","HP:0005518","HP:0000967"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"published":8}},"features":[{"hpoId":"HP:0001903","label":"Anemia","primary":true},{"hpoId":"HP:0004812","label":"B Acute Lymphoblastic Leukemia","primary":true},{"hpoId":"HP:0000978","label":"Bruising susceptibility","primary":true},{"hpoId":"HP:0001875","label":"Decreased total neutrophil count","primary":true},{"hpoId":"HP:0000421","label":"Epistaxis","primary":true},{"hpoId":"HP:0005518","label":"Increased mean corpuscular volume","primary":true},{"hpoId":"HP:0000967","label":"Petechiae","primary":true},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false}],"ledeHtml":"Any thrombocytopenia in which the cause of the disease is a mutation in the ETV6 gene that impair transcriptional repression and megakaryocyte maturation. It is characterized by lifelong thrombocytopenia, mild mucocutaneous bleeding, and variable red cell macrocytosis. Affected individuals have a significantly increased susceptibility to hematologic malignancies, including B‑cell ALL, myelodysplastic syndrome, CMML, and mixed‑phenotype acute leukemia, with onset ranging from childhood to adulthood. Functional studies show that pathogenic ETV6 variants disrupt DNA binding, alter nuclear localization, and exert dominant‑negative effects on hematopoiesis, providing a mechanistic basis for both the platelet phenotype and cancer predisposition.","mondoId":"MONDO:0014536","node":{"canonicalSlug":"thrombocytopenia-5","comparisons":[{"documentSha256":"46fa1652ac974f0af68b758649c028769b849a51fe0a44f01f3de58fe68cae5f","key":"legacy-hereditary-thrombocytopenia-and-hematologic-cancer-predisposition","kind":"legacy","label":"hereditary thrombocytopenia and hematologic cancer predisposition syndrome","memberIds":["MONDO:0011071","MONDO:0014536","MONDO:0100083"],"mondoId":"MONDO:0011071","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hereditary-thrombocytopenia-and-hematologic-cancer-predisposition.46fa1652ac974f0af68b758649c028769b849a51fe0a44f01f3de58fe68cae5f.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"thrombocytopenia 5","paragraphs":["Any thrombocytopenia in which the cause of the disease is a mutation in the ETV6 gene that impair transcriptional repression and megakaryocyte maturation. It is characterized by lifelong thrombocytopenia, mild mucocutaneous bleeding, and variable red cell macrocytosis. Affected individuals have a significantly increased susceptibility to hematologic malignancies, including B‑cell ALL, myelodysplastic syndrome, CMML, and mixed‑phenotype acute leukemia, with onset ranging from childhood to adulthood. Functional studies show that pathogenic ETV6 variants disrupt DNA binding, alter nuclear localization, and exert dominant‑negative effects on hematopoiesis, providing a mechanistic basis for both the platelet phenotype and cancer predisposition."],"scope":"exact","source":"MONDO","upstream":"https://clinicalgenome.org/affiliation/40028/, https://orcid.org/0000-0002-7437-8060, MONDO:patterns/disease_series_by_gene, PMID:25581430, PMID:25807284, PMID:27365488","url":"https://monarchinitiative.org/MONDO:0014536"},"ownColumnKeys":["population-795be56ceffdea34665e"],"publication":"published","relationships":[{"kind":"parent","label":"inherited bleeding disorder, platelet-type","mondoId":"MONDO:0000009","slug":null},{"kind":"parent","label":"hereditary thrombocytopenia and hematologic cancer predisposition syndrome","mondoId":"MONDO:0011071","slug":"hereditary-thrombocytopenia-and-hematologic-cancer-predisposition"},{"kind":"parent","label":"inherited thrombocytopenia","mondoId":"MONDO:0100241","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/25000"}],"translation":"published"},"records":[{"frequencyKind":"reported","key":"0d1742aaff912217a2aff6a768e5321f7b2411feb5c82121443b13c8d4fb212b","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616216","disease_name":"Thrombocytopenia 5","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000421","is_excluded":false,"label":"Epistaxis","onset_id":null,"reference":"PMID:25581430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"238631592896eda6532c9058390161d5660b59dcd7819648ce345ce482f6b5d1","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616216","disease_name":"Thrombocytopenia 5","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000967","is_excluded":false,"label":"Petechiae","onset_id":null,"reference":"PMID:25581430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3fde9746ba28d4b0de355813ca9d3fa6d855cfb9d6780bcb0823e0d3122af8a7","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616216","disease_name":"Thrombocytopenia 5","evidence":"PCS","frequency_raw":"2/13","hpo_id":"HP:0001875","is_excluded":false,"label":"Decreased total neutrophil count","onset_id":null,"reference":"PMID:25581430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"870cd129360ae10ae546ed9538fbbe4cccef54146abed86de8a8feaeb3895848","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616216","disease_name":"Thrombocytopenia 5","evidence":"PCS","frequency_raw":"23/23","hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"PMID:25581430;PMID:25807284","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b98e51d39845ac64a11d29076948b30f633189e8d1b25f69b62e36a45f15db7f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616216","disease_name":"Thrombocytopenia 5","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000978","is_excluded":false,"label":"Bruising susceptibility","onset_id":null,"reference":"PMID:25581430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c073894847c1ce19791a0f193c71e8675ed6db731e101f997ef9e7adc1ee4715","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616216","disease_name":"Thrombocytopenia 5","evidence":"PCS","frequency_raw":"1/13","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"PMID:25581430","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"caa90bde90ae08f10a2563c1bd7211b21dd2f19599dfe14415556ae1e015f192","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616216","disease_name":"Thrombocytopenia 5","evidence":"PCS","frequency_raw":"10/10","hpo_id":"HP:0005518","is_excluded":false,"label":"Increased mean corpuscular volume","onset_id":null,"reference":"PMID:25807284","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cb8ddb383fd0221b653e55320f4f1695f85e87277c387559f61cb3ea0aa30d00","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616216","disease_name":"Thrombocytopenia 5","evidence":"PCS","frequency_raw":"3/10","hpo_id":"HP:0004812","is_excluded":false,"label":"B Acute Lymphoblastic Leukemia","onset_id":null,"reference":"PMID:25807284","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014536\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://clinicalgenome.org/affiliation/40028/, https://orcid.org/0000-0002-7437-8060, MONDO:patterns/disease_series_by_gene, PMID:25581430, PMID:25807284, PMID:27365488</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Any thrombocytopenia in which the cause of the disease is a mutation in the ETV6 gene that impair transcriptional repression and megakaryocyte maturation. It is characterized by lifelong thrombocytopenia, mild mucocutaneous bleeding, and variable red cell macrocytosis. Affected individuals have a significantly increased susceptibility to hematologic malignancies, including B‑cell ALL, myelodysplastic syndrome, CMML, and mixed‑phenotype acute leukemia, with onset ranging from childhood to adulthood. Functional studies show that pathogenic ETV6 variants disrupt DNA binding, alter nuclear localization, and exert dominant‑negative effects on hematopoiesis, providing a mechanistic basis for both the platelet phenotype and cancer predisposition.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014536\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"thrombocytopenia-5","sourceDocuments":[{"name":"MONDO: thrombocytopenia 5","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014536"}],"sourceNote":"","synonyms":["ETV6 thrombocytopenia","ETV6-related thrombocytopenia with or without myeloid malignancy","THC5","thrombocytopenia 5","thrombocytopenia caused by mutation in ETV6"],"takeawayHtml":"","title":"thrombocytopenia 5"},"schemaVersion":1}
